Congress trades

Natera, Inc. (NTRA)

NASDAQ · Healthcare · 7 congress trades · last filed 11 months ago

7
Congress disclosures shown
20d
Median delay on the congress disclosures
of the 45 day limit
4/3
Purchases and sales in the disclosures shown

About Natera, Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Chief executive
Steven Leonard Chapman
Employees
6,138
Listed since
Jul 1, 2015
Market value
$47.3B
Price to earnings
-
Earnings per share
-$1.34
Dividend yield
-

www.natera.com

Earnings

6 reported quarters · next on Nov 5, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026-$0.47-$0.49$752.8M$661.2MEPS beatRevenue beat
Q1 FY2026reported May 7, 2026-$0.56-$0.54$696.6M$617.1MEPS missRevenue beat
Q4 FY2025reported Feb 26, 2026$0.35-$0.51$665.5M$604.0MEPS beatRevenue beat
Q3 FY2025reported Nov 6, 2025-$0.64-$0.39$592.2M$513.5MEPS missRevenue beat
Q2 FY2025reported Aug 7, 2025-$0.74-$0.62$546.6M$476.3MEPS missRevenue beat
Q1 FY2025reported May 8, 2025-$0.50-$0.64$501.8M$446.2MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 23, 2026
ExecutiveSalaryStock awardsOtherTotal
Steven ChapmanChief Executive Officer and President ​$854K$13.0M$1.1M$15.0M
Matthew RabinowitzExecutive Chairman ​$426K$10.4M$474K$11.3M
Michael BrophyChief Financial Officer ​$563K$4.5M$396K$5.5M
Solomon MoshkevichPresident, Clinical Diagnostics$505K$4.5M$362K$5.4M
John FeskoPresident, Chief Business Officer$505K$4.2M$362K$5.1M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Jpmorgan Chase & Co$3.5B12,865,346-3.9%8.98%
Blackrock, Inc.$3.0B10,914,608+2.2%7.62%
Price T Rowe Associates Inc$2.4B9,021,895-26.0%6.30%
Vanguard Capital Management LLC$1.7B6,228,216+3.7%4.35%
Vanguard Portfolio Management LLC$1.6B5,782,640+2.4%4.04%
FMR LLC$1.5B5,451,396+113.4%3.80%
Wellington Management Group LLP$1.1B4,040,738-15.3%2.82%
State Street Corp$992.3M3,655,618+7.0%2.55%
Duquesne Family Office LLC$864.9M3,186,306+4.0%2.22%
Geode Capital Management, LLC$744.6M2,750,013-0.9%1.92%
Franklin Resources Inc$739.9M2,725,903+9.7%1.90%
Castle Hook Partners LP$704.8M2,596,276+2.6%1.81%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next NTRA filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in NTRA

7 disclosures of 7 on record · median 20d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Josh GottheimerJointStockPurchase$1,001 - $15,000+84.3%S&P +14.0% · vs S&P 500 +70.3%Sep 22, 2025Oct 15, 202523d
Josh GottheimerJointStockPurchase$1,001 - $15,000+99.5%S&P +18.2% · vs S&P 500 +81.3%Aug 22, 2025Sep 5, 202514d
Josh GottheimerJointStockSale$1,001 - $15,000+136.1%S&P +21.3% · vs S&P 500 +114.8%Jul 22, 2025Aug 11, 202520d
Josh GottheimerJointStockPurchase$1,001 - $15,000+96.8%S&P +29.1% · vs S&P 500 +67.7%Nov 20, 2024Dec 5, 202415d
Daniel S. GoldmanStockSale$1,001 - $15,000+541.8%S&P +86.2% · vs S&P 500 +455.5%Apr 10, 2023May 19, 202339d
Daniel S. GoldmanStockPurchase$1,001 - $15,000+482.3%S&P +88.5% · vs S&P 500 +393.7%Mar 6, 2023Apr 17, 202342d
Bill HagertySelfStockSale (Partial)$1,001 - $15,000+217.4%S&P +85.0% · vs S&P 500 +132.5%Apr 20, 2021May 4, 202114d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

2 members · estimate, as of Sep 10, 2026

2 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Bill HagertyRepublican · Senate$250,001 - $500,0001.8%
Josh GottheimerDemocrat · House$1,001 - $15,000<0.1%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded NTRA?

Josh Gottheimer, Daniel S. Goldman, Bill Hagerty disclosed NTRA transactions in the filings shown here.

Which members of Congress hold NTRA?

2 members of Congress report a position in NTRA in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Bill Hagerty and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are NTRA trades disclosed?

Congressional disclosures took a median of 20 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track